Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Harvard Bioscience (HBIO) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.

  • Harvard Bioscience's Income towards Parent Company rose 7430.24% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.8 million, marking a year-over-year decrease of 27876.57%. This contributed to the annual value of -$12.4 million for FY2024, which is 26325.04% down from last year.
  • Latest data reveals that Harvard Bioscience reported Income towards Parent Company of -$1.2 million as of Q3 2025, which was up 7430.24% from -$2.3 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Income towards Parent Company high stood at $2.4 million for Q2 2022, and its period low was -$50.3 million during Q1 2025.
  • Moreover, its 5-year median value for Income towards Parent Company was -$1.3 million (2023), whereas its average is -$4.2 million.
  • The largest annual percentage gain for Harvard Bioscience's Income towards Parent Company in the last 5 years was 69048.78% (2022), contrasted with its biggest fall of 189411.76% (2022).
  • Harvard Bioscience's Income towards Parent Company (Quarter) stood at $590000.0 in 2021, then plummeted by 466.78% to -$2.2 million in 2022, then increased by 15.99% to -$1.8 million in 2023, then skyrocketed by 102.75% to $50000.0 in 2024, then plummeted by 2568.0% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$2.3 million for Q2 2025, and -$50.3 million during Q1 2025.